Microglial Advances in Neurodegenerative Diseases
Series: Advances in Immunology; 170;
- Publisher's listprice EUR 138.00
-
53 902 Ft (51 336 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 5 390 Ft off)
- Discounted price 48 513 Ft (46 202 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
53 902 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 1 August 2026
- ISBN 9780443470547
- Binding Hardback
- No. of pages258 pages
- Size 229x152 mm
- Weight 450 g
- Language English 700
Categories
Long description:
Microglial Advances in Neurodegenerative Diseases, Volume 170 in the Advances in Immunology series, presents current developments and comprehensive reviews focused on the role of microglia and neuroinflammation in neurological and psychiatric disorders. This volume brings together contributions from leading researchers, offering up-to-date insights into microglial biology in health and disease, as well as their involvement in major neurodegenerative conditions. Chapters in this new release explore Cross-talk between Tau and Neuro-glia Axis of Alzheimer’s Disease, Microglia in Health and Disease, Amyloid-beta (A?) and Neuroinflammation in Microglia, Chemokine Receptor CX3CR1 Interacts with Tau and Regulates Microglial Activity in Alzheimer’s Disease, and much more.
Additional chapters explore Human-Induced Pluripotent Stem Cells in Psychiatric Disorders, GPCR-Mediated Internalization and Endosomal Sorting of the Tau-GPCR Complex in Microglia, iPSC-Derived Microglia: A Cellular Platform for Tau and Alzheimer’s Disease Immunotherapy, Advancements in Invasive and Non-Invasive Neuromodulation for Parkinson’s Disease, LRRK2-I1371V Disrupts Microglial Membrane Homeostasis and Enhances ?-Synuclein Toxicity, Microglial Advances in Parkinson’s Disease, Microglial Advances in Alzheimer’s Disease, and more.
Table of Contents:
1. Cross-talk between Tau and Neuro-glia Axis of Alzheimer’s Disease
2. Microglia in Health and Disease
3. Amyloid-beta (A?) and Neuroinflammation in Microglia
4. Chemokine Receptor CX3CR1 Interacts with Tau and Regulates Microglial Activity in Alzheimer’s Disease
5. Human-Induced Pluripotent Stem Cells in Psychiatric Disorders
6. GPCR-Mediated Internalization and Endosomal Sorting of the Tau-GPCR Complex in Microglia
7. iPSC-Derived Microglia: A Cellular Platform for Tau and Alzheimer’s Disease Immunotherapy
8. Advancements in Invasive and Non-Invasive Neuromodulation for Parkinson’s Disease
9. LRRK2-I1371V Disrupts Microglial Membrane Homeostasis and Enhances ?-Synuclein Toxicity
10. Microglial Advances in Parkinson’s Disease
11. Microglial Advances in Alzheimer’s Disease
12. iPSC-Derived Microglial Advances in Amyotrophic Lateral Sclerosis (ALS)
13. Glial Advances in Neurodegenerative Diseases
14. Microglial Dynamics and Neuroinflammation in the Early Onset of Parkinson’s Disease
15. Microglial Advances in Psychiatric Disorders
16. Astroglial Advances in Neurodegenerative Diseases
17. Neuroinflammation in Parkinson’s Disease
